Halozyme Therapeutics Inc. Common Stock vs Haleon plc American Depositary Shares (Each representing two Ordinary Shares) — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.34 (market cap $12.58B), while Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.31 (market cap $40.01B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is far larger — about 3.2× Halozyme Therapeutics Inc. Common Stock's market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.14% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 1 Days on average.
| HALO | HLN | |
|---|---|---|
Market Cap | $12.58B | $40.01B |
Volume | 2,179,278 | 19,985,935 |
Sector | Health | Health |
52-Week High | $115.22 | $11.27 |
52-Week Low | $61.63 | $8.70 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $49.79B |
Dividend Yield | — | 2.14% |
Trailing returns across standard periods
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.
Read more on HLN →